KAITO vs Enzyme — how do they compare? KAITO trades at Rp7,239 (market cap Rp1,76T, Rp897,14M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: KAITO is far larger — about 13121.6× Enzyme's market cap, and KAITO's supply is capped (241,4M / 1B KAITO (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold KAITO for 9 Days and Enzyme for 29 Days on average.
| KAITO | MLN | |
|---|---|---|
Market Cap | Rp1,76T | Rp134,13M |
Volume (24h) | Rp897,14M | Rp104,56M |
Circulating Supply | 241,4M / 1B KAITO (25%) | 3,3M MLN |
Typical Hold Time | 9 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
KAITO is currently trading at Rp7,416 with a market cap of Rp1.79T, showing bearish technical signals overall despite some oscillators indicating potential buying opportunities. The token faces significant resistance at Rp7,884 and finds support at Rp7,264, with a relatively short average hold time of 9 days suggesting active trading. No major protocol updates or ecosystem developments have been reported recently.
The outlook remains cautious with technical indicators predominantly bearish, though oversold RSI levels suggest potential for short-term rebounds. Key risks include high volatility and limited liquidity, while opportunities may arise from any positive ecosystem developments or improved market sentiment in the crypto space.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
KAITO is the native token and foundational component of the AI-powered InfoFi network. It serves several important functions: aligning incentives, empowering participants, and fostering the development of a fair and efficient AI-driven information finance ecosystem.
Read more on KAITO →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →